🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Duaa H. Al-Rawi

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-9218-6513

Also affiliated with Kettering University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer”.

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100873
N/A
0DataRank · unranked
12 citations

Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal +4 more

Chromosomal instability as a source of genomic plasticity

Current Opinion in Genetics & Development(2022)10.1016/j.gde.2022.101913
N/A
0DataRank · unranked
40 citations

Samuel F. Bakhoum, Duaa H. Al-Rawi

Epigenetic dysregulation from chromosomal transit in micronuclei

Nature(2023)10.1038/s41586-023-06084-7
N/A
0DataRank · unranked
118 citations

Duaa H. Al-Rawi, Bhargavi Dameracharla, Ramya Raviram, Bailey S.C.L. Jones, Stephanie Stransky +27 more

The Search for Genomic Biomarkers of Response to Immunotherapy in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0048
N/A
0DataRank · unranked
8 citations

Nicole Rusk, Claire F. Friedman, Duaa H. Al-Rawi

Targeting chromosomal instability in patients with cancer

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00923-w
N/A
0DataRank · unranked
37 citations

Emanuele Lettera, Jun Li, Melody DiBona, Samuel F. Bakhoum, Duaa H. Al-Rawi

Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-4005
N/A
0DataRank · unranked
9 citations

Fergus Keane, Henry Walch, Joanne F. Chou, Jenna Sinopoli, Silvia Palladino +13 more

Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.12.009
N/A
0DataRank · unranked
2 citations

Aaron Praiss, Sarah Chiang, Kelly A. Devereaux, James Huang, Gabrielle Rizzuto +6 more

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.11.602772
N/A
0DataRank · unranked
11 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Matthew Zatzman, Duaa H. Al-Rawi, Adam C. Weiner +52 more

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

Nature(2025)10.1038/s41586-025-09240-3
N/A
0DataRank · unranked
39 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Duaa H. Al-Rawi, Matthew Zatzman, Adam C. Weiner +53 more